These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24504817)

  • 1. Mixed cryoglobulinemia-associated vasculitis.
    Zuo KJ; Ménard HA; Amre R; Colmegna I
    Arthritis Rheumatol; 2014 Feb; 66(2):443. PubMed ID: 24504817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in the treatment of HCV cryoglobulinemia vasculitis].
    Cacoub P
    Presse Med; 2011 Nov; 40(11):991-4. PubMed ID: 21664794
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasculitis in a patient with mixed cryoglobulinemia treated with rituximab biosimilar CT-P10: a case report.
    Vacchi C; Manfredi A; Salvarani C; Sebastiani M
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):102-105. PubMed ID: 33086972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis associated cryoglobulinemia].
    Pischke S; Cornberg M; Manns MP
    Internist (Berl); 2008 Mar; 49(3):297-304. PubMed ID: 18327517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryoglobulinemic vasculitis].
    Ciobanu V; Popescu D; Boicescu L; Manolescu N; Ionescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(5):385-94. PubMed ID: 2868501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cryoglobulinemic vasculitis].
    Blank N; Lorenz HM
    Z Rheumatol; 2016 Apr; 75(3):303-15. PubMed ID: 27034078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
    Terrier B; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
    Blood; 2012 Jun; 119(25):5996-6004. PubMed ID: 22474249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
    De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
    Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on managing chronic HCV in patients with mixed cryoglobulinaemia vasculitis.
    Zignego AL; Pawlotsky JM; Bondin M; Cacoub P
    Antivir Ther; 2018; 23(Suppl 2):1-9. PubMed ID: 30451151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
    Baerlecken NT; Schmidt RE
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vasculitis. Indications for plasma exchange].
    Guillevin L
    Presse Med; 1990 Jan 6-13; 19(1):11-2. PubMed ID: 1967828
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryoglobulinemia with acronecrosis not associated with hepatitis C infection: a case report.
    Ramírez Huaranga MA; Ramos Rodríguez CC; Bellido Pastrana D
    Reumatol Clin; 2012; 8(2):84-6. PubMed ID: 22089061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type I cryoglobulinemia with a fatal outcome].
    Echeverría B; Vitiello M; Abuchar A; Kerdel FA
    Actas Dermosifiliogr; 2011 Apr; 102(3):212-5. PubMed ID: 21376295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoglobulinemia vasculitis: an update.
    Terrier B; Cacoub P
    Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory vasculitis.
    Rutgers A; Kallenberg CG
    Autoimmun Rev; 2011 Sep; 10(11):702-6. PubMed ID: 21600312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revision on cryoglobulinaemia associated to neoplastic diseases.
    Molina-Garrido MJ; Guillén-Ponce C
    Clin Transl Oncol; 2007 Apr; 9(4):229-36. PubMed ID: 17462975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential cryoglobulinemic vasculitis with severe peripheral neuropathy and neurogenic muscular atrophy -- inducing remission by cascade filtration].
    Strunk J; Taborski U; Neeck G
    Z Rheumatol; 2002 Dec; 61(6):733-9. PubMed ID: 12491140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
    Perez-Alamino R; Espinoza LR
    Curr Rheumatol Rep; 2014 May; 16(5):420. PubMed ID: 24647999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatments of systemic vasculitides.
    Guillevin L
    Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):72-8. PubMed ID: 18181034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.